Molecular Formula | C16H16N2O3 |
Molar Mass | 284.31 |
Density | 1.245±0.06 g/cm3(Predicted) |
Melting Point | 172-175oC |
Solubility | DMSO: ≥ 35 mg/mL |
Appearance | Solid |
Color | Off-White |
pKa | 8.56±0.10(Predicted) |
Storage Condition | under inert gas (nitrogen or Argon) at 2-8°C |
In vitro study | As compared to the other class I and II histone deacetylases (HDACs) (HDAC1, 12 μM; HDAC2, 9 μM; HDAC3, 23μM; HDAC4, >33 μM; HDAC5, >33 μM; HDAC7, 13 μM; HDAC8, 120 nM; HDAC9, >33 μM), BRD73954 maintains excellent selectivity toward HDAC6 and HDAC8 with IC50 of 36 nM and 120 nM, respectively. Treatment with BRD73954 results in a robust increase in α -tubulin acetylation. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.517 ml | 17.586 ml | 35.173 ml |
5 mM | 0.703 ml | 3.517 ml | 7.035 ml |
10 mM | 0.352 ml | 1.759 ml | 3.517 ml |
5 mM | 0.07 ml | 0.352 ml | 0.703 ml |
trait | BRD73954 was white to off-white solid in appearance. |
Use | BRD73954 is a potent small molecule inhibitor of HDAC6 and hdac8. |
biological activity | BRD73954 is a potent and selective HDAC inhibitor, the IC50 for HDAC6 and HDAC8 were 36 nM and 120 nM, respectively. |